68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 96-97, 61-67
Abstract
No abstract availableKeywords
Funding Information
- Bhabha Atomic Research Centre
- Department of Atomic Energy, Government of India
This publication has 21 references indexed in Scilit:
- A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: Some observations towards possible improvement in in vivo efficacyNuclear Medicine and Biology, 2014
- Gallium(III) complexes of NOTA‐bis (phosphonate) conjugates as PET radiotracers for bone imagingContrast Media & Molecular Imaging, 2014
- Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxiaNuclear Medicine and Biology, 2013
- 68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future PerspectivesSeminars in Nuclear Medicine, 2011
- Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracersBioorganic & Medicinal Chemistry, 2011
- Synthesis and Characterization of Nitroimidazole Derivatives for 68Ga-Labeling and Testing in Tumor Xenografted MiceJournal of Medicinal Chemistry, 2010
- Initial results of hypoxia imaging using 1-α-d-(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole (18F-FAZA)European Journal of Nuclear Medicine and Molecular Imaging, 2009
- 18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck CancerJournal of Nuclear Medicine, 2008
- Bioreductive Drugs: from Concept to ClinicClinical Oncology, 2007
- A neutral lipophilic complex of 99mTc with a multidentate amine oximeThe International Journal of Applied Radiation and Isotopes, 1984